If patients expressed low levels of S100A4 and high levels of DKK1 in the tumor, the five-year survival was 90% (±7.0%) in the first cohort (Figure 8c) and 91% (±6.1%) in the second cohort (Figure 9e). The gene discussed is DKK1; the disease is neoplasm.